Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 10, Number 6—June 2004

Research

Candida parapsilosis Characterization in an Outbreak Setting

Duncan M. Kuhn*1, Pranab K. Mukherjee*, Thomas A. Clark†, Claude Pujol‡, Jyotsna Chandra*, Rana A. Hajjeh†, David W. Warnock†, David R. Soll‡, and Mahmoud A. Ghannoum*Comments to Author 
Author affiliations: *University Hospitals of Cleveland and Case Western Reserve University, Cleveland, Ohio, USA; †Centers for Disease Control and Prevention, Atlanta, Georgia, USA; ‡University of Iowa, Iowa City, Iowa, USA; 1Current affiliation: Division of Pulmonary and Critical Care, University of Washington Hospitals, Seattle, WA 98195, USA.

Main Article

Figure 6

Phospholipase expression by Candida parapsilosis clinical isolates. Phospholipase expression as determined by the colorimetric method is shown. C. albicans train M61 was included as it is a known phospholipase producer. (For details of the methods used, see text.) Cath, catheter; Bld, bloodstream; Spt, sputum; Hnd, hand; Pdf, peritoneal dialysis fluid.

Figure 6. Phospholipase expression by Candida parapsilosis clinical isolates. Phospholipase expression as determined by the colorimetric method is shown. C. albicans train M61 was included as it is a known phospholipase producer. (For details of the methods used, see text.) Cath, catheter; Bld, bloodstream; Spt, sputum; Hnd, hand; Pdf, peritoneal dialysis fluid.

Main Article

TOP